According to @godbole17, Leap Therapeutics announced a $50 million purchase of Zcash (ZEC), with the post referencing on-chain researcher @ad1_onchain as the source; source: @godbole17 on X. Given the potentially market-moving nature of this claim, traders should treat it as unconfirmed until corroborated by official company communications or filings and monitor ZEC spot volumes, order-book depth, and derivatives funding for reaction while managing position size accordingly; source: @godbole17 on X.

According to @CoinMarketCap, Nasdaq-listed Leap Therapeutics will rebrand to Cypherpunk Technologies and become a Zcash (ZEC) treasury company backed by the Winklevoss Twins, with a stated goal to acquire at least 5% of all ZEC, source: @CoinMarketCap. For traders, a corporate plan to accumulate a fixed share of supply can tighten exchange float and affect spot liquidity and derivatives metrics around ZEC as execution progresses, a setup directly tied to the accumulation plan reported by @CoinMarketCap, source: @CoinMarketCap.